Literature DB >> 8101444

Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adeninedinucleotide (NADH).

K Vrecko1, J G Birkmayer, J Krainz.   

Abstract

The activity of the tyrosine hydroxylase, the enzyme which is diminished in the brains of Parkinson patients, has been measured in cultured PC 12 rat phaeochromocytoma cells. In the same way dopamine content in the medium after incubating these cells with or without NADH was assayed. The experiment shows that NADH is able to increase the activity of the tyrosine hydroxylase and dopamine - production in PC 12 cells up to 6 times. The results provide evidence that NADH is able to stimulate dopamine - biosynthesis directly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101444     DOI: 10.1007/bf02251205

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  7 in total

1.  Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.

Authors:  W Kuhn; T Müller; R Winkel; S Danielczik; A Gerstner; R Häcker; C Mattern; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Purification of Angiotensin-Converting Enzyme (ACE) from Sheep Kidney and Inhibition Effect of Reduced Nicotinamide Adenine Dinucleotide (NADH) on Purified ACE Activity.

Authors:  Aysenur Kiylik; Vedat Turkoglu; Zehra Bas
Journal:  Cell Biochem Biophys       Date:  2021-10-07       Impact factor: 2.194

Review 3.  Is NADH effective in the treatment of Parkinson's disease?

Authors:  R H Swerdlow
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

4.  1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.

Authors:  J Liptrot; D Holdup; O Phillipson
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model.

Authors:  Won-Seok Choi; Richard D Palmiter; Zhengui Xia
Journal:  J Cell Biol       Date:  2011-03-07       Impact factor: 10.539

Review 6.  Emerging preclinical pharmacological targets for Parkinson's disease.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Oncotarget       Date:  2016-05-17

7.  Niacin Enhancement for Parkinson's Disease: An Effectiveness Trial.

Authors:  Raymond Chong; Chandramohan Wakade; Marissa Seamon; Banabihari Giri; John Morgan; Sharad Purohit
Journal:  Front Aging Neurosci       Date:  2021-06-17       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.